ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results

Ghobrial I., Rodriguez-Otero P., Koh Y., Martinez-Lopez J., Parmar G., Prince M., ...More

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.21, 2021 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 21
  • Publication Date: 2021
  • Journal Name: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Istanbul University Affiliated: No